113 related articles for article (PubMed ID: 3060430)
1. Propranolol increases prostacyclin synthesis in patients with essential hypertension.
Beckmann ML; Gerber JG; Byyny RL; LoVerde M; Nies AS
Hypertension; 1988 Dec; 12(6):582-8. PubMed ID: 3060430
[TBL] [Abstract][Full Text] [Related]
2. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent.
Gerber JG; LoVerde M; Byyny RL; Nies AS
Clin Pharmacol Ther; 1990 Oct; 48(4):424-30. PubMed ID: 2225702
[TBL] [Abstract][Full Text] [Related]
3. Hydralazine does not stimulate prostacyclin biosynthesis in hypertensive patients.
Gerber JG; Beckmann ML; Loverde M; Byyny RL; Nies AS
Am J Med Sci; 1990 Mar; 299(3):170-4. PubMed ID: 2107743
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with propranolol enhances the synthesis of prostaglandins E2 and I2 by the aorta of spontaneously hypertensive rats.
Nishimiya T; Daniell HB; Webb JG; Oatis J; Walle T; Gaffney TE; Halushka PV
J Pharmacol Exp Ther; 1990 Apr; 253(1):207-13. PubMed ID: 2109798
[TBL] [Abstract][Full Text] [Related]
6. Effects of non-steroidal anti-inflammatory drugs on prostacyclin and thromboxane biosynthesis in patients with mild essential hypertension.
Minuz P; Barrow SE; Cockcroft JR; Ritter JM
Br J Clin Pharmacol; 1990 Oct; 30(4):519-26. PubMed ID: 2291866
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin and thromboxane biosynthesis in mild essential hypertension.
Minuz P; Barrow SE; Cockcroft JR; Ritter JM
Hypertension; 1990 May; 15(5):469-74. PubMed ID: 2110113
[TBL] [Abstract][Full Text] [Related]
8. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants.
Ylikorkala O; Pekonen F; Viinikka L
J Clin Endocrinol Metab; 1986 Dec; 63(6):1307-12. PubMed ID: 3536979
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effect of enalapril in essential hypertension: role of prostacyclin.
Oparil S; Horton R; Wilkins LH; Irvin J; Hammett DK
Am J Med Sci; 1987 Dec; 294(6):395-402. PubMed ID: 2827471
[TBL] [Abstract][Full Text] [Related]
10. The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans.
Fitzgerald DJ; Roy L; Robertson RM; FitzGerald GA
Circulation; 1984 Aug; 70(2):297-302. PubMed ID: 6428771
[TBL] [Abstract][Full Text] [Related]
11. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
[TBL] [Abstract][Full Text] [Related]
12. Increased urinary 6-keto-PGF1 alpha excretion during water immersion is blunted by metoclopramide in normal man.
Minuz P; Coruzzi P; Paluani F; Ravanetti C; Lechi C; Delva P; Lechi A; Novarini A
J Endocrinol Invest; 1989 Oct; 12(9):597-600. PubMed ID: 2511238
[TBL] [Abstract][Full Text] [Related]
13. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin.
Balazy M; Brass EP; Gerber JG; Nies AS
Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630
[TBL] [Abstract][Full Text] [Related]
14. Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs.
Vesterqvist O; Gréen K
Prostaglandins; 1984 Jul; 28(1):139-54. PubMed ID: 6548317
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man.
Rosenkranz B; Fischer C; Weimer KE; Frölich JC
J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774
[TBL] [Abstract][Full Text] [Related]
17. Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: interaction with low dose acetylsalicylic acid.
Böger RH; Bode-Böger SM; Kramme P; Tsikas D; Gutzki FM; Frölich JC
Br J Clin Pharmacol; 1996 Dec; 42(6):721-7. PubMed ID: 8971427
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin biosynthesis in essential hypertension before and during treatment.
Ritter JM; Brett SE; Woods JD; Benjamin N; Stratton PD; Barrow SE
J Hum Hypertens; 1996 Jan; 10(1):37-42. PubMed ID: 8642189
[TBL] [Abstract][Full Text] [Related]
19. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry.
Daniel VC; Minton TA; Brown NJ; Nadeau JH; Morrow JD
J Chromatogr B Biomed Appl; 1994 Mar; 653(2):117-22. PubMed ID: 8205238
[TBL] [Abstract][Full Text] [Related]
20. Evidence that prostacyclin modulates the vascular actions of calcium in man.
Nadler JL; McKay M; Campese V; Vrbanac J; Horton R
J Clin Invest; 1986 Apr; 77(4):1278-84. PubMed ID: 3514678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
